Kanna Alkaloids: The Full Sceletium Profile, Explained

Kanna's effects come from a family of mesembrine-type alkaloids, chiefly mesembrine, mesembrenone, mesembrenol, and mesembranol, not from a single active ingredient. That is the whole idea, and it is the sentence worth remembering: kanna is a profile, not a molecule, and understanding the profile is what lets you read a label honestly.

Chemically, these are mesembrine-type alkaloids, a family of octahydroindole compounds that give the genus Sceletium its pharmacology. Their dual action was characterized by Harvey et al. (2011) in the Journal of Ethnopharmacology: as a group they inhibit the serotonin transporter (SERT) and inhibit the enzyme PDE4, two separate targets. Which member of the family dominates a given extract is what tilts it toward one pathway or the other. The deeper walk-through of that mechanism lives in how kanna works.

Four alkaloids do most of the talking in any discussion of kanna, with a fifth (Δ7-mesembrenone) rounding out the family. The table below is the at-a-glance version; the two headline molecules each get a full page of their own.

The shorthand: mesembrine is the serotonin-side, "uplift" alkaloid; mesembrenone is the PDE4-side, calmer and clearer-headed alkaloid (and is also serotonin-active, so it is not "inert" on serotonin, just tilted toward PDE4). Mesembrenol and mesembranol are the supporting cast, present in smaller amounts. For the deep dives, see mesembrine explained and mesembrenone explained.

Here is the single most useful idea in the whole subject, and the reason this page exists. Because mesembrine drives the serotonin side and mesembrenone drives the PDE4 side, the ratio between them, not just the total alkaloid content, is what shapes how a product feels. Two extracts can carry the same total-alkaloid percentage and still land differently because one is mesembrine-forward and the other mesembrenone-forward.

The rule of thumb: more mesembrine leans uplifting and strongly serotonergic; more mesembrenone leans calmer, clearer-headed, and more cognitive. This is why raw plant, traditional fermented kanna (kougoed), and standardized concentrates are not interchangeable even at matched doses, they sit at different points on the ratio. It is also why a bare milligram number tells you so little: it describes the mass of powder, not the balance of the profile inside it.

The ratio is not just theory, it maps onto real products, and the cleanest case study is the most-studied extract in the world. Zembrin, the patented standardized Sceletium extract from PLT Health Solutions, is deliberately built to a mesembrenone-forward, low-mesembrine profile, commonly reported at roughly 0.35 to 0.45% total alkaloids. That is a design choice, not a shortfall: a mesembrenone-forward extract aims at a consistent, calmer, clear-headed character and a reproducible batch-to-batch spec, which is exactly what makes it usable in controlled research.

At the other end sit the mesembrine-forward grades and concentrates, high-mesembrine material that leans warmer and more strongly serotonergic. So when a study reports a result "for kanna," it really means "for this one mesembrenone-forward standardized extract at this one dose," and it does not automatically transfer to raw plant or high-mesembrine concentrates. More on the standardized extract in Zembrin explained, and on the buying side in best kanna extract.

Mesembrine and mesembrenone are the headline pair, but they do not act alone. Three further mesembrine-type alkaloids round out the profile:

Mesembrenol and mesembranol, supporting alkaloids present in smaller amounts; they contribute to the overall character without being the headline driver of either the serotonin or the PDE4 pathway.

Δ7-mesembrenone, an additional mesembrine-type alkaloid in the mix, a structural relative of mesembrenone whose proportion shifts with fermentation and extraction.

The proportions of all of these move with how the plant is grown, fermented (the traditional kougoed step), and extracted, which is another reason preparations are not interchangeable. The full botanical and alkaloid picture lives in the science of Sceletium tortuosum.

Here is the practical payoff. When you read a kanna label, two numbers actually matter: the total-alkaloid percentage and, ideally, the specific profile, how that total splits between mesembrine and mesembrenone. A milligram figure on its own, "100mg extract per capsule," tells you the mass of powder, not the potency and not the balance.

The honest reality is that most brands disclose neither. Many print a dose in milligrams and, at best, a total-alkaloid floor, without breaking out the individual alkaloids. That is not automatically a bad product, but it is less information, and it is why our roundups weight disclosed alkaloid content and COA transparency, and why a stated mesembrine or mesembrenone figure earns extra trust. If a brand will not tell you the total-alkaloid content or the profile, you cannot really know what you are dosing. See the transparency scoring in best kanna extract.

The controlled human evidence for kanna is genuinely interesting and genuinely thin, and, crucially, it was mostly generated using one standardized, mesembrenone-forward extract (Zembrin), so it describes that alkaloid profile in particular.

Terburg et al. 2013 (Neuropsychopharmacology, n=16, fMRI; DOI 10.1038/npp.2013.183): a single 25mg dose reduced amygdala reactivity to fearful faces and reduced amygdala, hypothalamus coupling, an observed brain-imaging change to threat stimuli, not a clinical outcome.

Chiu et al. 2014 (Evid Based Complement Alternat Med, n=21, 3-week RCT): 25mg/day improved cognitive flexibility and executive function versus placebo on the cognitive tasks measured.

The alkaloid profile carries kanna's single most important safety rule directly with it. Because the mesembrine-type alkaloids raise serotonin, mesembrine strongly and mesembrenone partially, kanna must not be combined with SSRIs, SNRIs, MAOIs, or other serotonergic drugs (including certain migraine medications and supplements) without a doctor's guidance. Stacking two things that both raise serotonin is the mechanism behind serotonin-related adverse reactions, which is why this caution flows from the pharmacology rather than being a generic disclaimer. Kanna is also best avoided in pregnancy.

Note that a mesembrenone-forward extract does not sidestep this: mesembrenone is also serotonin-transporter active and travels alongside mesembrine in every real extract, so the rule applies to any kanna, regardless of profile. On its own, in the studied range, kanna's tolerability data looks reassuring; combined with another serotonergic drug, the serotonin action turns from interesting into a real interaction risk. For the full picture see kanna and antidepressants.